Adenoviral transgene ubiquitination enhances mouse immunization and class I presentation by human dendritic cells

Human Gene Therapy

Volumn 14, Issue 14, 2003, Pages 1319-1332

  Rouard, Helene ^a   Klonjkowski, Bernard ^b   Marquet, Jeanine ^a   Lahet, Chantal ^a   Mercier, Stephanie ^b   Andrieu, Muriel ^c   Maison, Patrick ^a   Molinier Frenkel, Valerie ^a   Eloit, Marc ^b   Farcet, Jean Pierre ^a   Langlade Demoyen, Pierre ^d   Delfau Larue, Marie Helene ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c Hôpital Cochin ^*  (France)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CANCER ANTIBODY; CD8 ANTIGEN; CHROMIUM 51; GAMMA INTERFERON; HLA ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; GENETIC CODE; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TECHNIQUE; TRANSGENE; VACCINATION;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIGEN-PRESENTING CELLS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; DENDRITIC CELLS; EPITOPES; GENE THERAPY; GENE TRANSFER TECHNIQUES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOTHERAPY, ACTIVE; INTERFERON TYPE II; K562 CELLS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; TRANSDUCTION, GENETIC; TRANSGENES; UBIQUITIN;

ADENOVIRIDAE; ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 10744220796     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322319408     Document Type: Article

References (66)

1. ANDRIEU, M., LOING, E., DESOUTTER, J.F., CONNAN, F., CHOPPIN, J., GRAS-MASSE, H., HANAU, D., DAUTRY-VARSAT, A., GUILLET, J.G., and HOSMALIN, A. (2000). Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation. Eur. J. Immunol. 30, 3256-3265.
2. ARTHUR, J.F., BUTTERFIELD, L.H., ROTH, M.D., BUI, L.A., KIERTSCHER, S.M., LAU, R., DUBINETT, S., GLASPY, J., MCBRIDE, W.H., and ECONOMOU, J.S. (1997). A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4, 17-25.
3. BANCHEREAU, J., and STEINMAN, R.M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252.
4. BELICH, M.P., GLYNNE, R.J., SENGER, G., SHEER, D., and TROWSDALE, J. (1994). Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr. Biol. 4, 769-776.
5. BOON, T., CEROTTINI, J.C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., and VAN PEL, A. (1994). Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12, 337-365.
6. BROSSART, P., GOLDRATH, A.W, BUTZ, E.A., MARTIN, S., and BEVAN, M.J. (1997). Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158, 3270-3276.
7. BUTTERFIELD, L.H., JILANI, S.M., CHAKRABORTY, N.G., BUI, L.A., RIBAS, A., DISSETTE, V.B., LAU, R., GAMRADT, S.C., GLASPY, J.A., MCBRIDE, W.H., MUKHERJI, B., and ECONOMOU, J.S. (1998). Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. J. Immunol. 161, 5607-5613.
8. CHARTIER, C., DEGRYSE, E., GANTZER, M., DIETERLE, A., PAVIRANI, A., and MEHTALI, M. (1996). Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol, 70, 4805-4810.
9. CHEN, P.W., WANG, M., BRONTE, V., ZHAI, Y., ROSENBERG, S.A., and RESTIFO, N.P. (1996). Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J. Immunol. 156, 224-231.
10. DIAO, J., SMYTHE, J.A., SMYTH, C., ROWE, P.B., and ALEXANDER, I.E. (1999). Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro. Gene Ther. 6, 845-853.
11. DIEBOLD, S.S., LEHRMANN, H., KURSA, M., WAGNER, E., COTTEN, M., and ZENKE, M. (1999). Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum. Gene Ther. 10, 775-786.
12. DIETZ, A.B., and VUK-PAVLOVIC, S. (1998). High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 91, 392-398.
13. DITTEL, B.N., VISINTIN, I., MERCHANT, R.M., and JANEWAY, C.A. Jr. (1999). Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol. 163, 32-39.
14. DRISCOLL, J., BROWN, M.G., FINLEY, D., and MONACO, J.J. (1993). MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365, 262-264.
15. FIRAT, H., GARCIA-PONS, F., TOURDOT, S., PASCOLO, S., SCARDINO, A., GARCIA, Z., MICHEL, M.L., JACK, R.W., JUNG, G., KOSMATOPOULOS, K., MATEO, L., SUHRBIER, A., LEMONNIER, F.A., and LANGLADE-DEMOYEN, P. (1999). H-2 class I knockout, HLA-A2.1-transgenic mice: A versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur. J. Immunol. 29, 3112-3121.
16. FLANAGAN, B., PRINGLE, C.R., and LEPPARD, K.N. (1997). A recombinant human adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice. J. Gen. Virol. 78, 991-997.
17. GONDA, D.K., BACHMAIR, A., WUNNING, I., TOBIAS., J.W., LANE, W.S., and VARSHAVSKY, A. (1989). Universality and structure of the N-end rule. J. Biol. Chem. 264, 16700-16712.
18. GONG, J., CHEN, L., CHEN, D., KASHIWABA, M., MANOME, Y., TANAKA, T., and KUFE, D. (1997). Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Ther. 4, 1023-1028.
19. GOULDER, P.J., SEWELL, A.K., LALLOO, D.G., PRICE, D.A., WHELAN, J.A., EVANS, J., TAYLOR, G.P., LUZZI, G., GIAN-GRANDE, P., PHILLIPS, R.E., and MCMICHAEL, A.J. (1997). Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation. J. Exp. Med. 185, 1423-1433.
20. GRANT, E.P., MICHALEK, M.T., GOLDBERG, A.L., and ROCK, K.L. (1995). Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J. Immunol. 155, 3750-3758.
21. HERSHKO, A., and CIECHANOVER, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
22. HIRSCHOWITZ, E.A., LEONARD, S., SONG, W., FERRIS, B., LEOPOLD, P.L., LEWIS, J.J., BOWNE, W.B., WANG, S., HOUGHTON, A.N., and CRYSTAL, R.G. (1998). Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma. Gene Ther. 5, 975-983.
23. HISAMATSU, H., SHIMBARA, N., SAITO, Y., KRISTENSEN, P., HENDIL, K.B., FUJIWARA, T., TAKAHASHI, E., TANAHASHI, N., TAMURA, T., ICHIHARA, A., and TANAKA, K. (1996). Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma. J. Exp. Med. 183, 1807-1816.
24. JUILLARD, V., VILLEFROY, P., GODFRIN, D., PAVIRANI, A., VENET, A., and GUILLET, J.G. (1995). Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur. J. Immunol. 25, 3467-3473.
25. KAPLAN, J.M., YU, Q., PIRAINO, S.T., PENNINGTON, S.E., SHANKARA, S., WOODWORTH, L.A., and ROBERTS, B.L. (1999). Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens. J. Immunol. 163, 699-707.
26. KOZAK, M. (1987). An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148.
27. LELOUARD, H., GATTI, E., CAPPELLO, F., GRESSER, O., CAMOSSETO, V., and PIERRE, P. (2002). Transient aggregation of ubiquitinated proteins during dendritic cell maturation. Nature 417, 177-182.
28. LINETTE, G.P., SHANKARA, S., LONGERICH, S., YANG, S., DOLL, R., NICOLETTE, C., PREFFER, F.I., ROBERTS, B.L., and HALUSKA, F.G. (2000). In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma. J. Immunol. 164, 3402-3412.
29. LUCKEY, C.J., MARTO, J.A., PARTRIDGE, M., HALL, E., WHITE, F.M., LIPPOLIS, J.D., SHABANOWITZ, J., HUNT, D.F., and ENGELHARD, V.H. (2001). Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J. Immunol. 167, 1212-1221.
30. LUDEWIG, B., JUNT, T., HENGARTNER, H., and ZINKERNAGEL, R.M. (2001). Dendritic cells in autoimmune diseases. Curr. Opin. Immunol. 13, 657-662.
31. MACAGNO, A., KUEHN, L., DE GIULI, R., and GROETTRUP, M. (2001). Pronounced up-regulation of the PA28alpha/beta proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation. Eur. J. Immunol. 31, 3271-3280.
32. MARUYAMA, K., AKIYAMA, Y., NARA-ASHIZAWA, N., HOJO, T., CHENG, J.Y., MIZUGUCHI, H., HAYAKAWA, T., and YAMAGUCHI, K. (2001). Adenovirus-Mediated MUC1 gene transduction into human blood-derived dendritic cells. J. Immunother. 24, 345-353.
33. MOREL, S., LEVY, F., BURLET-SCHILTZ, O., BRASSEUR, F., PROBST-KEPPER, M., PEITREQUIN, A.L., MONSARRAT, B., VAN VELTHOVEN, R., CEROTTINI, J.C., BOON, T., GAIRIN, J.E., and VAN DEN EYNDE, B.J. (2000). Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12, 107-117.
34. PAMER, E., and CRESSWELL, P. (1998). Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16, 323-358.
35. PARDOLL, D.M. (1998). Cancer vaccines. Nat. Med. 4, 525-531.
36. PASCOLO, S., BERVAS, N., URE, J.M., SMITH, A.G., LEMONNIER, F.A., and PERARNAU, B. (1997). HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J. Exp. Med. 185, 2043-2051.
37. PEREZ-DIEZ, A., BUTTERFIELD, L.H., LI, L., CHAKRABORTY, N.G., ECONOMOU, J.S., and MUKHERJI, B. (1998). Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene. Cancer Res. 58, 5305-5309.
38. RIBAS, A., BUTTERFIELD, L.H., MCBRIDE, W.H., JILANI, S.M., BUI, L.A., VOLLMER, C.M., LAU, R., DISSETTE, V.B., HU, B., CHEN, A.Y., GLASPY, J.A., and ECONOMOU, J.S. (1997). Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res. 57, 2865-2869.
39. RIBAS, A., BUTTERFIELD, L.H., MCBRIDE, W.H., DISSETTE, V.B., KOH, A, VOLLMER, C.M., HU, B, CHEN, A.Y., GLASPY, J.A., and ECONOMOU, J.S. (1999). Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic ceils. Cancer Gene Ther. 6, 523-536.
40. ROCK, K.L., and GOLDBERG, A.L. (1999). Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17, 739-779.
41. RODRIGUES, E.G., ZAVALA, F., EICHINGER, D., WILSON, J.M., and TSUJI, M. (1997). Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J. Immunol. 158, 1268-1274.
42. RODRIGUEZ, S., ZHANG, J., and WHITTON, J.L. (1997). DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71, 8497-8503.
43. ROUARD, H., LEON, A., KLONJKOWSKI, B., MARQUET, J., TENNEZE, L., PLONQUET, A., AGRAWAL, S.G., ABASTADO, J.P., ELOIT, M., FARCET, J.P., and DELFAU-LARUE, M.H. (2000). Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacity. J. Immunol. Methods 241, 69-81.
44. ROUARD, H., MARQUET, J., LEON, A., MAISON, P., HAIOUN, C., COPIE-BERGMAN, C., PLONQUET, A., FARCET, J.P., and DELFAU-LARUE, M.H. (2002). IL-12 Secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells. J. Immunother. 25, 324-333.
45. SALTER, R.D., and CRESSWELL, P. (1986). Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 5, 943-949.
46. SCHULER, G., and STEINMAN, R.M. (1997). Dendritic cells as adjuvants for immune-mediated resistance to tumors. J. Exp. Med. 186, 1183-1187.
47. SCHULTZ, E.S., CHAPIRO, J., LURQUIN, C., CLAVEROL, S., BURLET-SCHILTZ, O., WARNIER, G., RUSSO, V., MOREL, S., LEVY, F., BOON, T., VAN DEN EYNDE, B.J., and VAN DER BRUGGEN, P. (2002). The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J. Exp. Med. 195, 391-399.
48. SEWELL, A.K., PRICE, D.A., TEISSERENC, H., BOOTH, B.L., Jr., GILEADI, U., FLAVIN, F.M., TROWSDALE, J., PHILLIPS, R.E., and CERUNDOLO, V. (1999). IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J. Immunol. 162, 7075-7079.
49. SINGH, R.A., WU, L., and BARRY, M.A. (2002). Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine. J. Immunol. 168, 379-391.
50. SONG, W., KONG, H.L., CARPENTER, H., TORII, H., GRANSTEIN, R., RAFII, S., MOORE, M.A., and CRYSTAL, R.G. (1997). Dendritic cells genetically modified with an adenovirus vector encoding the eDNA for a model antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186, 1247-1256.
51. TOBERY, T.W., and SILICIANO, R.F. (1997). Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185, 909-920.
52. TOES, R.E., HOEBEN, R.C., VAN DER VOORT, E.I., RESSING, M.E., VAN DER EB, A.J., MELIEF, C.J., and OFFRINGA, R. (1997). Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion. Proc. Natl. Acad. Sci. U.S.A. 94, 14660-14665.
53. URETA-VIDAL, A., FIRAT, H., PERARNAU, B., and LEMONNIER, F.A. (1999). Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice. J. Immunol. 163, 2555-2560.
54. VAN DEN EYNDE, B.J., and MOREL, S. (2001). Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr. Opin. Immunol. 13, 147-153.
55. VAN DER BURG, S.H., VISSEREN, M.J., BRANDT, R.M., KAST, W.M., and MELIEF, C.J. (1996). Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 156, 3308-3314.
56. VAN PEL, A., DE PLAEN, E., DUFFOUR, M.T., WARNIER, G., UYTTENHOVE, C., PERRICAUDET, M., and BOON, T. (2001). Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes. Cancer Immunol. Immunother. 49, 593-602.
57. VELDERS, M.P., WEIJZEN, S., EIBEN, G.L., ELMISHAD, A.G., KLOETZEL, P.M., HIGGINS, T., CICCARELLI, R.B., EVANS, M., MAN, S., SMITH, L., and KAST, W.M. (2001). Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine. J. Immunol. 166, 5366-5373.
58. WALKER, B.D., CHAKRABARTI, S., MOSS, B., PARADIS, T.J., FLYNN, T., DURNO, A.G., BLUMBERG, R.S., KAPLAN, J.C., HIRSCH, M.S., and SCHOOLEY, R.T. (1987). HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345-348.
59. WALKER, B.D., FLEXNER, C., PARADIS, T.J., FULLER, T.C., HIRSCH, M.S., SCHOOLEY, R.T., and MOSS, B. (1988). HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240, 64-66.
60. WAN, Y., BRAMSON, J., CARTER, R., GRAHAM, F., and GAULDIE, J. (1997). Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum. Gene Ther. 8, 1355-1363.
61. WIBORG, O., PEDERSEN, M.S., WIND, A., BERGLUND, L.E., MARCKER, K.A., and VUUST, J. (1985). The human ubiquitin multigene family: Some genes contain multiple directly repeated ubiquitin coding sequences. EMBO J. 4, 755-759.
62. WILKINSON, K.D, URBAN, M.K., and HAAS, A.L. (1980). Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes, J. Biol. Chem. 255, 7529-7532.
63. WU, Y., and KIPPS, T.J. (1997). Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes. J. Immunol. 159, 6037-6043.
64. XIANG, Z.Q., YANG, Y., WILSON, J.M., and ERTL, H.C. (1996). A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219, 220-227.
65. YEWDELL, J.W., BENNINK, J.R., and HOSAKA, Y. (1988). Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239, 637-640.
66. ZHONG, L., GRANELLI-PIPERNO, A., CHOI, Y., and STEINMAN, R.M. (1999). Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur. J. Immunol. 29, 964-972.